Margaretha G.M. Roemer

Papers

Total Citations

H-Index

About

Dr. Margaretha G.M. Roemer is a pioneering molecular pathologist whose work is reshaping cancer diagnostics through the clinical implementation of whole genome sequencing (WGS). Her research centers on precision oncology, biomarker discovery, and the translation of comprehensive genomic profiling from bench to bedside. In her landmark 2021 study, "Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics," which has garnered 86 citations, Dr. Roemer demonstrated that WGS using fresh-frozen tumor tissue and matched blood samples can serve as a single, all-inclusive genetic test—a critical advance as biopsies grow smaller and the demand for multi-biomarker screening intensifies. This work has positioned her at the forefront of efforts to replace fragmented testing panels with a unified genomic approach, promising faster, more complete tumor characterization. Her contributions are vital for enabling personalized treatment strategies, particularly in cancers where tissue is scarce. Dr. Roemer’s validation studies have set new standards for clinical WGS, influencing diagnostic guidelines and inspiring further research into scalable, cost-effective genomic testing. Her dedication to bridging genomics and patient care marks her as a leader in the next wave of cancer diagnostics.